HEADER LIGASE/LIGASE INHIBITOR 03-SEP-09 3IWY TITLE CRYSTAL STRUCTURE OF HUMAN MDM2 COMPLEXED WITH D-PEPTIDE (12 RESIDUES) COMPND MOL_ID: 1; COMPND 2 MOLECULE: D-PEPTIDE INHIBITOR; COMPND 3 CHAIN: B, D; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: P53 BINDING DOMAIN; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE MDM2; COMPND 8 CHAIN: A, C; COMPND 9 FRAGMENT: UNP RESIDUES 25-109, SWIB DOMAIN; COMPND 10 SYNONYM: P53-BINDING PROTEIN MDM2, ONCOPROTEIN MDM2, DOUBLE MINUTE 2 COMPND 11 PROTEIN, HDM2; COMPND 12 EC: 6.3.2.-; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: SYNTHETIC PEPTIDE, SEQUENCE FOUND BY PHAGE DISPLAY SOURCE 4 SCREENING; SOURCE 5 MOL_ID: 2; SOURCE 6 SYNTHETIC: YES; SOURCE 7 OTHER_DETAILS: MDM2 SEQUENCE ACCURS NATURALLY IN HUMANS KEYWDS MDM2, P53 BINDING DOMAIN, D-PEPTIDE ACTIVATOR OF P53, HOST-VIRUS KEYWDS 2 INTERACTION, LIGASE, METAL-BINDING, NUCLEUS, PHOSPHOPROTEIN, PROTO- KEYWDS 3 ONCOGENE, UBL CONJUGATION PATHWAY, ZINC-FINGER, LIGASE-LIGASE KEYWDS 4 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.PAZGIER,W.LU REVDAT 4 13-JUL-11 3IWY 1 VERSN REVDAT 3 11-AUG-10 3IWY 1 JRNL REVDAT 2 28-APR-10 3IWY 1 JRNL REVDAT 1 21-APR-10 3IWY 0 JRNL AUTH M.LIU,C.LI,M.PAZGIER,C.LI,Y.MAO,Y.LV,B.GU,G.WEI,W.YUAN, JRNL AUTH 2 C.ZHAN,W.Y.LU,W.LU JRNL TITL D-PEPTIDE INHIBITORS OF THE P53-MDM2 INTERACTION FOR JRNL TITL 2 TARGETED MOLECULAR THERAPY OF MALIGNANT NEOPLASMS. JRNL REF PROC.NATL.ACAD.SCI.USA V. 398 200 2010 JRNL REFN ISSN 0027-8424 JRNL PMID 20660730 JRNL DOI 10.1073/PNAS.1008930107 REMARK 2 REMARK 2 RESOLUTION. 1.93 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0070 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.93 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 3 NUMBER OF REFLECTIONS : 10509 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 522 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.93 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.98 REMARK 3 REFLECTION IN BIN (WORKING SET) : 740 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.54 REMARK 3 BIN R VALUE (WORKING SET) : 0.2450 REMARK 3 BIN FREE R VALUE SET COUNT : 33 REMARK 3 BIN FREE R VALUE : 0.3000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1589 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 106 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.85 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.11000 REMARK 3 B22 (A**2) : -0.39000 REMARK 3 B33 (A**2) : 0.27000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.10000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.284 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.207 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.145 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.074 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.938 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.910 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1636 ; 0.019 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2211 ; 1.899 ; 2.022 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 187 ; 6.811 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 58 ;43.253 ;23.103 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 286 ;14.045 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 8 ;17.037 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 245 ; 0.386 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1198 ; 0.010 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 951 ; 0.952 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1544 ; 1.517 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 685 ; 2.654 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 667 ; 4.056 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 26 A 107 REMARK 3 RESIDUE RANGE : A 1 A 148 REMARK 3 ORIGIN FOR THE GROUP (A): 9.0588 -9.6162 24.0239 REMARK 3 T TENSOR REMARK 3 T11: 0.0053 T22: 0.0495 REMARK 3 T33: 0.0050 T12: -0.0016 REMARK 3 T13: -0.0011 T23: -0.0011 REMARK 3 L TENSOR REMARK 3 L11: 0.0852 L22: 0.4363 REMARK 3 L33: 0.2599 L12: -0.0039 REMARK 3 L13: -0.0398 L23: -0.0080 REMARK 3 S TENSOR REMARK 3 S11: -0.0190 S12: 0.0008 S13: 0.0089 REMARK 3 S21: 0.0198 S22: 0.0078 S23: 0.0348 REMARK 3 S31: -0.0028 S32: -0.0191 S33: 0.0112 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3IWY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-SEP-09. REMARK 100 THE RCSB ID CODE IS RCSB054968. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11041 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.930 REMARK 200 RESOLUTION RANGE LOW (A) : 28.280 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.11700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.93 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.96 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.47100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3EQS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): NULL REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05 M POTASSIUM PHOSPHATE MONOBASIC, REMARK 280 20% PEG 8,000, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 273K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 23.25150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5820 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5940 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 25 REMARK 465 VAL A 108 REMARK 465 VAL A 109 REMARK 465 GLU C 25 REMARK 465 VAL C 109 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 DPR D 4 N - CA - C ANGL. DEV. = 17.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 45 175.37 -51.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 DPR B 4 -16.1 D D OUTSIDE RANGE REMARK 500 DPR D 4 -23.4 D D OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1YCR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN MDM2 WITH P53 REMARK 900 RELATED ID: 3EQS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN MDM2 IN COMPLEX WITH A 12-MER REMARK 900 PEPTIDE INHIBITOR REMARK 900 RELATED ID: 3IUX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN MDM2 IN COMPLEX WITH A POTENT REMARK 900 MINIATURE PROTEIN INHIBITOR (18-RESIDUES) DBREF 3IWY A 25 109 UNP Q00987 MDM2_HUMAN 25 109 DBREF 3IWY C 25 109 UNP Q00987 MDM2_HUMAN 25 109 DBREF 3IWY B 1 12 PDB 3IWY 3IWY 1 12 DBREF 3IWY D 1 12 PDB 3IWY 3IWY 1 12 SEQRES 1 B 12 DAS DTR DTR DPR DLE DAL DPN DGL DAL DLE DLE DAR SEQRES 1 D 12 DAS DTR DTR DPR DLE DAL DPN DGL DAL DLE DLE DAR SEQRES 1 A 85 GLU THR LEU VAL ARG PRO LYS PRO LEU LEU LEU LYS LEU SEQRES 2 A 85 LEU LYS SER VAL GLY ALA GLN LYS ASP THR TYR THR MET SEQRES 3 A 85 LYS GLU VAL LEU PHE TYR LEU GLY GLN TYR ILE MET THR SEQRES 4 A 85 LYS ARG LEU TYR ASP GLU LYS GLN GLN HIS ILE VAL TYR SEQRES 5 A 85 CYS SER ASN ASP LEU LEU GLY ASP LEU PHE GLY VAL PRO SEQRES 6 A 85 SER PHE SER VAL LYS GLU HIS ARG LYS ILE TYR THR MET SEQRES 7 A 85 ILE TYR ARG ASN LEU VAL VAL SEQRES 1 C 85 GLU THR LEU VAL ARG PRO LYS PRO LEU LEU LEU LYS LEU SEQRES 2 C 85 LEU LYS SER VAL GLY ALA GLN LYS ASP THR TYR THR MET SEQRES 3 C 85 LYS GLU VAL LEU PHE TYR LEU GLY GLN TYR ILE MET THR SEQRES 4 C 85 LYS ARG LEU TYR ASP GLU LYS GLN GLN HIS ILE VAL TYR SEQRES 5 C 85 CYS SER ASN ASP LEU LEU GLY ASP LEU PHE GLY VAL PRO SEQRES 6 C 85 SER PHE SER VAL LYS GLU HIS ARG LYS ILE TYR THR MET SEQRES 7 C 85 ILE TYR ARG ASN LEU VAL VAL HET DAS B 1 8 HET DTR B 2 14 HET DTR B 3 14 HET DPR B 4 7 HET DLE B 5 8 HET DAL B 6 5 HET DPN B 7 11 HET DGL B 8 9 HET DAL B 9 5 HET DLE B 10 8 HET DLE B 11 8 HET DAR B 12 12 HET DAS D 1 8 HET DTR D 2 14 HET DTR D 3 14 HET DPR D 4 7 HET DLE D 5 8 HET DAL D 6 5 HET DPN D 7 11 HET DGL D 8 9 HET DAL D 9 5 HET DLE D 10 8 HET DLE D 11 8 HET DAR D 12 12 HETNAM DAS D-ASPARTIC ACID HETNAM DTR D-TRYPTOPHAN HETNAM DPR D-PROLINE HETNAM DLE D-LEUCINE HETNAM DAL D-ALANINE HETNAM DPN D-PHENYLALANINE HETNAM DGL D-GLUTAMIC ACID HETNAM DAR D-ARGININE FORMUL 1 DAS 2(C4 H7 N O4) FORMUL 1 DTR 4(C11 H12 N2 O2) FORMUL 1 DPR 2(C5 H9 N O2) FORMUL 1 DLE 6(C6 H13 N O2) FORMUL 1 DAL 4(C3 H7 N O2) FORMUL 1 DPN 2(C9 H11 N O2) FORMUL 1 DGL 2(C5 H9 N O4) FORMUL 1 DAR 2(C6 H15 N4 O2 1+) FORMUL 5 HOH *106(H2 O) HELIX 1 1 DPR B 4 DAR B 12 1 9 HELIX 2 2 DPR D 4 DAR D 12 1 9 HELIX 3 3 LYS A 31 VAL A 41 1 11 HELIX 4 4 THR A 49 ARG A 65 1 17 HELIX 5 5 ASP A 80 GLY A 87 1 8 HELIX 6 6 GLU A 95 ARG A 105 1 11 HELIX 7 7 LYS C 31 VAL C 41 1 11 HELIX 8 8 THR C 49 ARG C 65 1 17 HELIX 9 9 ASP C 80 GLY C 87 1 8 HELIX 10 10 GLU C 95 ARG C 105 1 11 SHEET 1 A 2 ILE A 74 TYR A 76 0 SHEET 2 A 2 SER A 90 SER A 92 -1 O PHE A 91 N VAL A 75 SHEET 1 B 2 ARG C 29 PRO C 30 0 SHEET 2 B 2 LEU C 107 VAL C 108 -1 O VAL C 108 N ARG C 29 SHEET 1 C 3 TYR C 67 ASP C 68 0 SHEET 2 C 3 GLN C 71 TYR C 76 -1 O ILE C 74 N ASP C 68 SHEET 3 C 3 SER C 90 SER C 92 -1 O PHE C 91 N VAL C 75 LINK C DAS B 1 N DTR B 2 1555 1555 1.33 LINK C DTR B 2 N DTR B 3 1555 1555 1.33 LINK C DTR B 3 N DPR B 4 1555 1555 1.36 LINK C DPR B 4 N DLE B 5 1555 1555 1.33 LINK C DLE B 5 N DAL B 6 1555 1555 1.32 LINK C DAL B 6 N DPN B 7 1555 1555 1.33 LINK C DPN B 7 N DGL B 8 1555 1555 1.34 LINK C DGL B 8 N DAL B 9 1555 1555 1.34 LINK C DAL B 9 N DLE B 10 1555 1555 1.33 LINK C DLE B 10 N DLE B 11 1555 1555 1.34 LINK C DLE B 11 N DAR B 12 1555 1555 1.33 LINK C DAS D 1 N DTR D 2 1555 1555 1.34 LINK C DTR D 2 N DTR D 3 1555 1555 1.33 LINK C DTR D 3 N DPR D 4 1555 1555 1.35 LINK C DPR D 4 N DLE D 5 1555 1555 1.34 LINK C DLE D 5 N DAL D 6 1555 1555 1.33 LINK C DAL D 6 N DPN D 7 1555 1555 1.32 LINK C DPN D 7 N DGL D 8 1555 1555 1.35 LINK C DGL D 8 N DAL D 9 1555 1555 1.34 LINK C DAL D 9 N DLE D 10 1555 1555 1.33 LINK C DLE D 10 N DLE D 11 1555 1555 1.35 LINK C DLE D 11 N DAR D 12 1555 1555 1.33 CISPEP 1 DTR B 3 DPR B 4 0 12.88 CISPEP 2 DTR D 3 DPR D 4 0 8.73 CRYST1 33.569 46.503 49.353 90.00 92.35 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029789 0.000000 0.001221 0.00000 SCALE2 0.000000 0.021504 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020279 0.00000 MASTER 335 0 24 10 7 0 0 6 0 0 0 16 END